MedPath

Predictive Value of PS Application in Premature Infants With RDS

Not yet recruiting
Conditions
Respiratory Distress Syndrome
Registration Number
NCT05772247
Lead Sponsor
The First Hospital of Jilin University
Brief Summary

A multicenter prospective study was conducted to compare the predictive value of 6-zone, 10-zone, and 12-zone LUS scores for PS application in early and late preterm infants.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
1392
Inclusion Criteria
  1. Hospital admission within 2 hours after birth;
  2. The diagnosis was RDS;
  3. Parents agree to attend
Exclusion Criteria
  1. chromosomal abnormalities or complex congenital malformations;
  2. congenital pulmonary disease;
  3. severe sepsis, disseminated intravascular coagulation, septic shock and other critical conditions;
  4. LUS and blood gas analysis have been examined before the application of alveolar surfactant.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether the patient uses ps (pulmonary surfactant)2023.2-2023.12

The standards used by PS are based on the European consensus

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.